Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.4233/H.R.8109 - Save Struggling Hospitals Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; issues related to MedPAC; implementation of H.R. 1.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FRESENIUS KABI USA, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to domestic manufacturing of essential medicines; issues related to access to and availability of generic medicines; issues related to IV bag safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Source: Senate LDA
| VALNEVA USA, INC |
| 6 |
| 2024 |
| VALISURE | 5 | 2024 |
| EDIBLE BRANDS, LLC | 4 | 2026 |
| AMERICAN HEALTH CARE ASSOCIATION | 3 | 2024 |
| ANTIMICROBIALS WORKING GROUP | 3 | 2024 |
| COGNOSANTE | 3 | 2024 |
| HAPPIEST BABY, INC. | 3 | 2024 |
| VIMO, INC | 3 | 2025 |
| ACCENTURE FEDERAL SERVICES LLC | 2 | 2026 |
| BLUEPRINT BIOSECURITY ACTION | 2 | 2026 |
| FRESENIUS KABI USA, LLC | 2 | 2026 |
| GRINDR, LLC | 2 | 2025–2026 |
Issues related to H.R. 1 implementation and CMS contracting
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to H.R. 1 implementation and CMS contracting; H.R. 5235, Skills-Based Federal Contracting Act
Skills-Based Federal Contracting Act of 2025
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R. 5235, Skills-Based Federal Contracting Act.
Skills-Based Federal Contracting Act of 2025
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to H.R. 1 implementation and CMS contracting; H.R. 5235, Skills-Based Federal Contracting Act
Skills-Based Federal Contracting Act of 2025
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R. 5235, Skills-Based Federal Contracting Act.
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Hemp Enforcement, Modernization, and Protection Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
Save Struggling Hospitals Act
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.4233/H.R.8109 - Save Struggling Hospitals Act; issues related to hospital reimbursement, generally.
Save Struggling Hospitals Act
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.4233/H.R.8109 - Save Struggling Hospitals Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; issues related to MedPAC; implementation of H.R. 1.
Save Struggling Hospitals Act
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.4233/H.R.8109 - Save Struggling Hospitals Act; reauthorization of the Dr. Lorna Breen Health Care Provider Protection Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Cannabinoid Safety and Regulation Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
Hemp Planting Predictability Act
Client: EDIBLE BRANDS, LLC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R.7024/S.3686, Hemp Planting Predictability Act
S.4233/H.R.8109 - Save Struggling Hospitals Act; issues related to hospital reimbursement, generally.
S.4233/H.R.8109 - Save Struggling Hospitals Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; issues related to MedPAC; implementation of H.R. 1.
S.4233/H.R.8109 - Save Struggling Hospitals Act; reauthorization of the Dr. Lorna Breen Health Care Provider Protection Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: VIMO, INC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R. 1, issues related to state-based marketplaces
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to H.R. 1 implementation and government contracting
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NAVA PBC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to H.R. 1 implementation and government contracting
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: VIMO, INC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
H.R. 1, issues related to state-based marketplaces
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Black Maternal Health Momnibus Act
Client: HAPPIEST BABY, INC · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Rural health care issues, generally; Medicare Area Wage Index; S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Rural health care issues, generally; Medicare Area Wage Index; S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally.
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Client: WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Equality in women's sports; H.R. 4984, The D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Client: WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Equality in women's sports; H.R. 4984, The D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Client: WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Equality in women's sports; H.R. 4984, The D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act.
Protecting America from Seasonal and Pandemic Influenza Act of 2023
Client: COALITION TO STOP FLU · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Long-Term Care Workforce Support Act
Client: AMERICAN HEALTH CARE ASSOCIATION · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
CMS staffing mandate; S.4120 - Long-Term Care Workforce Support Act; Issues related to staffing and workforce support, generally; policies impacting nursing homes and assisted living, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Rural health care issues, generally; Medicare Area Wage Index; S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Save Rural Hospitals Act of 2023
Client: BALLAD HEALTH · Firm: DB3, LLC (FKA THE DASCHLE GROUP)
Rural health care issues, generally; Medicare Area Wage Index; S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally.
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R. 909, Moms Matter Act
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R. 909, Moms Matter Act
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
H.R.7024/S.3686, Hemp Planting Predictability Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
BLUEPRINT BIOSECURITY ACTION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to biodefense preparedness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCENTURE FEDERAL SERVICES LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to electronic health record modernization and technology modernization, in general
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
H.R. 5235, Skills-Based Federal Contracting Act.
Issues related to proposed rule on small business size standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
H.R. 5235, Skills-Based Federal Contracting Act.
Issues related to proposed rule on small business size standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Issues related to equality in women's sports and growth of women's soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
S.4233/H.R.8109 - Save Struggling Hospitals Act; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Medical countermeasure development, stockpiling, and funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; issues related to seasonal influenza vaccine development framework.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ACCENTURE FEDERAL SERVICES LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · RR
VET - Issues related to electronic health record modernization; issues related to technology modernization, in general; TRA - Issues related to technology modernization; MMM - Issues related to Medicare and Medicaid technology modernization
VET - Issues related to electronic health record modernization; issues related to technology modernization, in general; TRA - Issues related to technology modernization; MMM - Issues related to Medicare and Medicaid technology modernization
VET - Issues related to electronic health record modernization; issues related to technology modernization, in general; TRA - Issues related to technology modernization; MMM - Issues related to Medicare and Medicaid technology modernization
BLUEPRINT BIOSECURITY ACTION via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · RR
Issues related to biodefense preparedness
FRESENIUS KABI USA, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · third_quarter · RR
Issues related to domestic manufacturing of essential medicines; issues related to access to and availability of generic medicines, generally.
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
H.R.7024/S.3686, Hemp Planting Predictability Act
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Issues related to H.R. 1 implementation and CMS contracting; H.R. 5235, Skills-Based Federal Contracting Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
S.4233/H.R.8109 - Save Struggling Hospitals Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; issues related to MedPAC; implementation of H.R. 1.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; issues related to seasonal influenza vaccine development framework.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; issues related to seasonal influenza vaccine development framework.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to procurement reform and agency restructuring; issues related to AI pilots.
Issues related to H.R. 1 implementation and CMS contracting
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
S.4233/H.R.8109 - Save Struggling Hospitals Act; reauthorization of the Dr. Lorna Breen Health Care Provider Protection Act; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · Q1
Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)
H.R.7024/S.3686, Hemp Planting Predictability Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EDIBLE BRANDS, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2026 · first_quarter · RR
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
Issues related to the 2025 hemp ban and regulation of low-dose, hemp-derived CBD/THC products.
GRINDR, LLC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
IVF and surrogacy access for same sex couples; PrEP and HIV test kit access
PEPFAR funding; international human rights as it relates to the LGBTQ+ community
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Issues related to H.R. 1 implementation and government contracting
Issues related to procurement reform and agency restructuring
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · fourth_quarter · Q4
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to H.R. 1 implementation and government contracting
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIMO, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · 3T
H.R. 1, issues related to state-based marketplaces
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; issues related to global mpox response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · 3T
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NAVA PBC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · third_quarter · RR
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
HCR - Issues related to H.R. 1 implementation and government contracting; VET - Issues related to program implementation and agency contracting.
VIMO, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
H.R. 1, issues related to state-based marketplaces
Filing targets: SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally; H.R. 1, provisions related to provider taxes and state-directed payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; issues related to global mpox response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.
Issues related to preparedness for H5N1.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VIMO, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · second_quarter · RR
Issues impacting state-based marketplaces
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Issues related to equality in women's sports and the growth of womens soccer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; issues related to global mpox response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.
Issues related to preparedness for H5N1.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2025 · first_quarter · Q1
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VALISURE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · 4T
Issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy, generally; FY25 Milcon-VA appropriations, issues related to pharmaceutical safety and efficacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Equality in women's sports; H.R. 4984, The D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; issues related to global mpox response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · fourth_quarter · Q4
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · 3T
Issues related to vaccine coverage and cost-sharing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Issues related to Section 301 tariffs
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R.909 Moms Matter Act; H.R.3305 - Black Maternal Health Momnibus Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA)
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Equality in women's sports; H.R. 4984, The D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALISURE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy, generally; FY25 Milcon-VA appropriations, issues related to pharmaceutical safety and efficacy.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Issues related to vaccine coverage and cost-sharing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · Q3
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; issues related to global mpox response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON SOCCER PROPERTIES, LLC D/B/A WASHINGTON SPIRIT via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · third_quarter · RR
Equality in women's sports; H.R. 4984, The D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act
VALNEVA USA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · 1A
Issues related to vaccine coverage and cost-sharing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VALISURE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COGNOSANTE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
FY24 National Defense Authorization Act and FY24 Department of Defense appropriations, provisions related to LiDAR technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; FY25 NDAA, provisions related to biothreat vaccinations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, provisions related to stockpiles and threat assessment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Issues related to vaccine coverage and cost-sharing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · 2T
Issues related to antibiotic development and antimicrobial resistance.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEALTH CARE ASSOCIATION via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · 2T
CMS staffing mandate; S.4120 - Long-Term Care Workforce Support Act; Issues related to staffing and workforce support, generally; policies impacting nursing homes and assisted living, generally.
Filing targets: SENATE
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · Q2
Issues related to coverage and policy for medical devices for infant sleep; issues related to maternal mortality and perinatal care, generally; H.R.937, Tech To Save Moms Act; H.R. 909, Moms Matter Act
Issues related to Section 301 tariffs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HAPPIEST BABY, INC via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · second_quarter · RR
Issues related to Section 301 tariffs; issues related to coverage and policy for medical devices for infant sleep.
Issues related to Section 301 tariffs; issues related to coverage and policy for medical devices for infant sleep.
VALISURE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Issues related to vaccine coverage and cost-sharing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COGNOSANTE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
FY24 National Defense Authorization Act and FY24 Department of Defense appropriations, provisions related to LiDAR technology.
Issues related to supply chain modernization, EHRM implementation, and VistA modernization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; FY25 NDAA, provisions related to biothreat vaccinations.
Filing targets: Executive Office of the President (EOP), SENATE
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, provisions related to stockpiles and threat assessment.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act; FY25 Labor-HHS Appropriations, funding related to public health, pandemic preparedness, and flu planning and response.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIALS WORKING GROUP via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
Issues related to antibiotic development and antimicrobial resistance.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEALTH CARE ASSOCIATION via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · Q1
CMS staffing mandate; Issues related to staffing and workforce support, generally; policies impacting nursing homes and assisted living, generally.
Filing targets: SENATE
VALNEVA USA, INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RA
Issues related to vaccine coverage and cost-sharing
BALLAD HEALTH via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Rural health care issues, generally; Medicare Area Wage Index; S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally.
Rural health care issues, generally; Medicare Area Wage Index; S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally.
BAVARIAN NORDIC INC. via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Medical countermeasure development, stockpiling, and funding; reauthorization of the Pandemic and All-Hazards Preparedness Act.
BIPARTISAN COMMISSION ON BIODEFENSE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act
Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazards Preparedness Act
COGNOSANTE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Issues related to enrollment and program management; issues related to supply chain modernization, EHRM implementation, and VistA modernization; National Defense Authorization Act and Department of Defense appropriations, provisions related to LiDAR technology.
Issues related to enrollment and program management; issues related to supply chain modernization, EHRM implementation, and VistA modernization; National Defense Authorization Act and Department of Defense appropriations, provisions related to LiDAR technology.
Issues related to enrollment and program management; issues related to supply chain modernization, EHRM implementation, and VistA modernization; National Defense Authorization Act and Department of Defense appropriations, provisions related to LiDAR technology.
COALITION TO STOP FLU via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Protecting America from Seasonal and Pandemic Influenza Act; reauthorization of the Pandemic All-Hazards Preparedness Act.
VALISURE via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
AMERICAN HEALTH CARE ASSOCIATION via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Issues impacting long term and post-acute care providers, generally.
Issues impacting long term and post-acute care providers, generally.
ANTIMICROBIALS WORKING GROUP via DB3, LLC (FKA THE DASCHLE GROUP)
2024 · first_quarter · RR
Policy and reimbursement issues related to antibiotic development and antimicrobial resistance.
Policy and reimbursement issues related to antibiotic development and antimicrobial resistance.